CARGO Non Current Liabilities Total from 2010 to 2024
| CRGX Stock | 15.73 0.09 0.57% |
Non Current Liabilities Total | First Reported 2010-12-31 | Previous Quarter 26.5 M | Current Value 27.8 M | Quarterly Volatility 8.8 M |
Check CARGO Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CARGO Therapeutics,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 2.4 M or Selling General Administrative of 22 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.47. CARGO financial statements analysis is a perfect complement when working with CARGO Therapeutics, Valuation or Volatility modules.
CARGO |
Latest CARGO Therapeutics,'s Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of CARGO Therapeutics, Common over the last few years. It is CARGO Therapeutics,'s Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CARGO Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
| Timeline |
CARGO Non Current Liabilities Total Regression Statistics
| Arithmetic Mean | 5,493,493 | |
| Geometric Mean | 3,008,245 | |
| Coefficient Of Variation | 160.17 | |
| Mean Deviation | 5,775,122 | |
| Median | 2,230,000 | |
| Standard Deviation | 8,799,117 | |
| Sample Variance | 77.4T | |
| Range | 26.5M | |
| R-Value | 0.58 | |
| Mean Square Error | 55.2T | |
| R-Squared | 0.34 | |
| Significance | 0.02 | |
| Slope | 1,143,517 | |
| Total Sum of Squares | 1083.9T |
CARGO Non Current Liabilities Total History
About CARGO Therapeutics, Financial Statements
CARGO Therapeutics, investors use historical fundamental indicators, such as CARGO Therapeutics,'s Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CARGO Therapeutics,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Total | 26.5 M | 27.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CARGO Stock Analysis
When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.